Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer

被引:12
作者
Wang, Yuhan [1 ]
Zhou, Haijian [1 ]
Zhong, Guanglei [1 ]
Fu, Zhaojie [1 ]
Peng, Yu [1 ]
Yao, Tingting [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gynecol Oncol, 107 Yan Jiang West Rd, Guangzhou 510120, Peoples R China
[2] Sun Yat Sen Univ, Key Lab Malignant Tumor Gene Regulat & Target The, Guangzhou, Peoples R China
关键词
venous thromboembolism; epithelial ovarian cancer; predictive model; predictive factor; nomogram; RECEPTOR EXPRESSION; RISK; THROMBOSIS; SURVIVAL; IMPACT;
D O I
10.1177/10760296221095558
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To identify predictive factors and develop a nomogram to predict the probability of venous thromboembolism for epithelial ovarian cancer patients. Methods: Our study cohort was composed of 208 EOC patients who had received initial treatment in Sun Yat-sen Memorial Hospital from January 2016 to March 2020. Clinicopathological variables predictive of VTE were identified using univariate logistic analysis. A multivariate logistic regression model was used to select the predictive factors used for nomogram. The accuracy of nomogram was evaluated by the Concordance index (C-index), the area under the receiver-operator characteristic (ROC) curve, area under concentration-time curve (AUC) and the calibration curve. Results: Advancing age (hazard ratio [HR], 1.042; 95% confidence interval [CI], 1.000-1.085; P = .048), higher D-dimer level (HR, 1.144; 95%CI, 1.020-1.283; P = .022), lower PR immunohistochemical positive rate (HR, 0.186; 95%CI, 0.034-1.065; P = .059) and higher Ki67 immunohistochemical positive rate (HR, 4.502; 95%CI, 1.637-12.380; P = .004) were found to be independent risk factors for VTE, and were used to construct the nomogram. The C-index for VTE prediction of the nomogram was 0.75. Conclusions: We constructed and validated a nomogram able to quantify the risk of VTE for EOC patients, which can be applied in recognizing EOC patients with high risk of VTE.
引用
收藏
页数:8
相关论文
共 28 条
[1]   Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival [J].
Abu Saadeh, Feras ;
Norris, Lucy ;
O'Toole, Sharon ;
Gleeson, Noreen .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 170 (01) :214-218
[2]   Risk Assessment Scores for Cancer-Associated Venous Thromboembolic Disease [J].
Angelini, Dana ;
Khorana, Alok A. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (05) :469-478
[3]   The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patients [J].
Barber, Emma L. ;
Clarke-Pearson, Daniel L. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (04)
[4]   P53 IMMUNOHISTOCHEMISTRY - A WORD OF CAUTION [J].
BATTIFORA, H .
HUMAN PATHOLOGY, 1994, 25 (05) :435-437
[5]   Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer [J].
Black, Destin ;
Iasonos, Alexia ;
Ahmed, Hina ;
Chi, Dennis S. ;
Barakat, Richard R. ;
Abu-Rustum, Nadeem R. .
GYNECOLOGIC ONCOLOGY, 2007, 107 (01) :66-70
[6]   Malignancies, prothrombotic mutations, and the risk of venous thrombosis [J].
Blom, JW ;
Doggen, CJM ;
Osanto, S ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06) :715-722
[7]   Risk factors for deep venous thrombosis in women with ovarian cancer [J].
Ebina, Yasuhiko ;
Uchiyama, Mihoko ;
Imafuku, Hitomi ;
Suzuki, Kaho ;
Miyahara, Yoshiya ;
Yamada, Hideto .
MEDICINE, 2018, 97 (23)
[8]   Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival [J].
Gary, T. ;
Belaj, K. ;
Steidl, K. ;
Pichler, M. ;
Eisner, F. ;
Stoeger, H. ;
Hafner, F. ;
Froehlich, H. ;
Samonigg, H. ;
Pilger, E. ;
Brodmann, M. .
BRITISH JOURNAL OF CANCER, 2012, 107 (08) :1244-1248
[9]   A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study [J].
Gerotziafas, Grigoris T. ;
Taher, Ali ;
Abdel-Razeq, Hikmat ;
AboElnazar, Essam ;
Spyropoulos, Alex C. ;
El Shemmari, Salem ;
Larsen, Annette K. ;
Elalamy, Ismail .
ONCOLOGIST, 2017, 22 (10) :1222-1231
[10]   Prevention of VTE in Nonorthopedic Surgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].
Gould, Michael K. ;
Garcia, David A. ;
Wren, Sherry M. ;
Karanicolas, Paul J. ;
Arcelus, Juan I. ;
Heit, John A. ;
Samama, Charles M. .
CHEST, 2012, 141 (02) :E227S-E277S